{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:38:50Z","timestamp":1768963130425,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007301","name":"Harvard University Center for AIDS Research","doi-asserted-by":"publisher","award":["5P30AI060354-19"],"award-info":[{"award-number":["5P30AI060354-19"]}],"id":[{"id":"10.13039\/100007301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10461-025-04857-x","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T02:27:17Z","timestamp":1755570437000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PrEP Use Likelihood Among People Who Use Opioid Drugs: Understanding Clinical Correlates Along the Opioid Use Disorder Treatment Cascade"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-7787","authenticated-orcid":false,"given":"Matthew C.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-5043","authenticated-orcid":false,"given":"Conall","family":"O\u2019Cleirigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7225-1675","authenticated-orcid":false,"given":"Abigail W.","family":"Batchelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"4857_CR1","first-page":"1","volume":"25","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. Diagnoses of HIV infection in the united States and dependent areas, 2017. HIV Surveillance Rep. 2015;25:1\u201382.","journal-title":"HIV Surveillance Rep"},{"key":"4857_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/10826084.2019.1673419","volume":"55","author":"A Edeza","year":"2020","unstructured":"Edeza A, Bazzi A, Salhaney P, Biancarelli D, Childs E, Mimiaga MJ, et al. HIV pre-exposure prophylaxis for people who inject drugs: the context of co-occurring injection-and sexual-related HIV risk in the US Northeast. Subst Use Misuse. 2020;55:525\u201333.","journal-title":"Subst Use Misuse"},{"key":"4857_CR3","doi-asserted-by":"publisher","first-page":"111013","DOI":"10.1016\/j.drugalcdep.2023.111013","volume":"253","author":"AW Batchelder","year":"2023","unstructured":"Batchelder AW, Heo M, Foley JD, Sullivan MC, Lum P, Valverde IP, et al. Shame and stigma in association with the HCV cascade to cure among people who inject drugs. Drug Alcohol Depend. 2023;253:111013.","journal-title":"Drug Alcohol Depend"},{"key":"4857_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drugpo.2015.07.015","volume":"27","author":"HL Cooper","year":"2016","unstructured":"Cooper HL, Linton S, Kelley ME, Ross Z, Wolfe ME, Chen Y-T, et al. Racialized risk environments in a large sample of people who inject drugs in the united States. Int J Drug Policy. 2016;27:43\u201355.","journal-title":"Int J Drug Policy"},{"key":"4857_CR5","doi-asserted-by":"publisher","first-page":"113809","DOI":"10.1016\/j.socscimed.2021.113809","volume":"275","author":"M Felsher","year":"2021","unstructured":"Felsher M, Ziegler E, Amico KR, Carrico A, Coleman J, Roth AM. PrEP just isn\u2019t my priority: adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in philadelphia, PA USA. Soc Sci Med. 2021;275:113809.","journal-title":"Soc Sci Med"},{"key":"4857_CR6","doi-asserted-by":"publisher","first-page":"103872","DOI":"10.1016\/j.drugpo.2022.103872","volume":"109","author":"N Palmateer","year":"2022","unstructured":"Palmateer N, Hamill V, Bergenstrom A, Bloomfield H, Gordon L, Stone J, et al. Interventions to prevent HIV and hepatitis C among people who inject drugs: latest evidence of effectiveness from a systematic review (2011 to 2020). Int J Drug Policy. 2022;109:103872.","journal-title":"Int J Drug Policy"},{"key":"4857_CR7","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.2105\/AJPH.2016.303380","volume":"106","author":"AJ Mitsch","year":"2016","unstructured":"Mitsch AJ, Hall HI, Babu AS. Trends in HIV infection among persons who inject drugs: united states and Puerto Rico, 2008\u20132013. Am J Public Health. 2016;106:2194\u2013201.","journal-title":"Am J Public Health"},{"key":"4857_CR8","unstructured":"National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention. AtlasPlus [Internet]. 2024; Available from: https:\/\/www.cdc.gov\/nchhstp\/about\/atlasplus.html"},{"key":"4857_CR9","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s10461-022-03908-x","volume":"27","author":"KS Kenny","year":"2023","unstructured":"Kenny KS, Kolla G, Greig S, Bannerman M, Phillips D, Altenberg J, et al. Association of illicit fentanyl use with injection risk practices among people who inject drugs. AIDS Behav. 2023;27:1757\u201365.","journal-title":"AIDS Behav"},{"key":"4857_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","volume":"74","author":"BH Lambdin","year":"2019","unstructured":"Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019;74:299\u2013304.","journal-title":"Int J Drug Policy"},{"key":"4857_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.annepidem.2020.03.011","volume":"45","author":"LD Williams","year":"2020","unstructured":"Williams LD, Ibragimov U, Tempalski B, Stall R, Johnson AS, Wang G, et al. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992\u20132013. Ann Epidemiol. 2020;45:12\u201323.","journal-title":"Ann Epidemiol"},{"key":"4857_CR12","unstructured":"Fukuda HD. Ongoing HIV infections among persons who inject drugs in Boston. Bureau of infectious disease and laboratory sciences. Executive Office of Health and Human Services, Commonwealth of Massachusetts; 2024."},{"key":"4857_CR13","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083\u201390.","journal-title":"Lancet"},{"key":"4857_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385:595\u2013608.","journal-title":"N Engl J Med"},{"key":"4857_CR15","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","volume":"25","author":"CB Mistler","year":"2021","unstructured":"Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25:1490\u2013506.","journal-title":"AIDS Behav"},{"key":"4857_CR16","doi-asserted-by":"publisher","first-page":"ofab658","DOI":"10.1093\/ofid\/ofab658","volume":"9","author":"C Brokus","year":"2022","unstructured":"Brokus C, Sarah Kattakuzhy, Gayle B, Narayanan S, Davis A, Cover A, et al. Suboptimal uptake, retention, and adherence of daily oral prexposure prophylaxis among people with opioid use disorder receiving hepatitis C virus treatment. Open Forum Infect Dis. 2022;9:ofab658.","journal-title":"Open Forum Infect Dis"},{"key":"4857_CR17","doi-asserted-by":"crossref","unstructured":"Walters SM, Frank D, Van Ham B, Jaiswal J, Muncan B, Earnshaw V et al. PrEP care continuum engagement among persons who inject drugs: rural and urban differences in stigma and social infrastructure. AIDS Behav. 2022;26:1308\u201320.","DOI":"10.1007\/s10461-021-03488-2"},{"key":"4857_CR18","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1080\/10826084.2020.1823419","volume":"55","author":"SM Walters","year":"2020","unstructured":"Walters SM, Kral AH, Simpson KA, Wenger L, Bluthenthal RN. HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco. Subst Use Misuse. 2020;55:2016\u20138.","journal-title":"Subst Use Misuse"},{"key":"4857_CR19","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s10461-019-02767-3","volume":"24","author":"ST Allen","year":"2020","unstructured":"Allen ST, O\u2019Rourke A, White RH, Smith KC, Weir B, Lucas GM, et al. Barriers and facilitators to PrEP use among people who inject drugs in rural appalachia: a qualitative study. AIDS Behav. 2020;24:1942\u201350.","journal-title":"AIDS Behav"},{"key":"4857_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/690386","volume":"2013","author":"E Buckingham","year":"2013","unstructured":"Buckingham E, Schrage E, Cournos F. Why the treatment of mental disorders is an important component of HIV prevention among people who inject drugs. Adv Prev Med. 2013;2013:1\u20139.","journal-title":"Adv Prev Med"},{"key":"4857_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s10461-022-03853-9","volume":"27","author":"S Tross","year":"2023","unstructured":"Tross S, Spector AY, Ertl MM, Berg H, Turrigiano E, Hoffman S. A qualitative study of barriers and facilitators of PrEP uptake among women in substance use treatment and syringe service programs. AIDS Behav. 2023;27:1162\u201372.","journal-title":"AIDS Behav"},{"key":"4857_CR22","doi-asserted-by":"publisher","first-page":"100288","DOI":"10.1016\/j.dadr.2024.100288","volume":"13","author":"T Verinumbe","year":"2024","unstructured":"Verinumbe T, Lucas GM, Zook K, Weir B, Landry M, Page KR, et al. Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in baltimore, MD. Drug Alcohol Depend Rep. 2024;13:100288.","journal-title":"Drug Alcohol Depend Rep"},{"key":"4857_CR23","doi-asserted-by":"publisher","first-page":"e0217811","DOI":"10.1371\/journal.pone.0217811","volume":"14","author":"MD Morris","year":"2019","unstructured":"Morris MD, Andrew E, Tan JY, Maher L, Hoff C, Darbes L, et al. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships. PLoS One. 2019;14:e0217811.","journal-title":"PLoS One"},{"key":"4857_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s11013-024-09870-8","volume":"48","author":"S Mars","year":"2024","unstructured":"Mars S, Ondocsin J, Koester KA, Mars V, Mars G, Ciccarone D. I heard of PrEP\u2014I didn\u2019t think I needed it. Understanding the formation of HIV risk perception among people who inject drugs. Cult Med Psychiatry. 2024;48:747\u201367.","journal-title":"Cult Med Psychiatry"},{"key":"4857_CR25","doi-asserted-by":"publisher","first-page":"113824","DOI":"10.1016\/j.socscimed.2021.113824","volume":"275","author":"AW Batchelder","year":"2021","unstructured":"Batchelder AW, Foley JD, Kim J, Thiim A, Kelly J, Mayer K, et al. Intersecting internalized stigmas and HIV self-care among men who have sex with men and who use substances. Soc Sci Med. 2021;275:113824.","journal-title":"Soc Sci Med"},{"key":"4857_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"4857_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/apc.2022.0068","volume":"36","author":"AR Bazzi","year":"2022","unstructured":"Bazzi AR, Valasek CJ, Streuli SA, Vera CF, Harvey-Vera A, Philbin MM, et al. Long-acting injectable human immunodeficiency virus pre-exposure prophylaxis preferred over other modalities among people who inject drugs: findings from a qualitative study in California. AIDS Patient Care STDs. 2022;36:254\u201362.","journal-title":"AIDS Patient Care STDs"},{"key":"4857_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","volume":"45","author":"AR Williams","year":"2019","unstructured":"Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abus. 2019;45:1\u201310.","journal-title":"Am J Drug Alcohol Abus"},{"key":"4857_CR29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10461-016-1650-0","volume":"21","author":"R Shrestha","year":"2017","unstructured":"Shrestha R, Altice FL, Huedo-Medina TB, Karki P, Copenhaver M. Willingness to use pre-exposure prophylaxis (PrEP): an empirical test of the information-motivation-behavioral skills (IMB) model among high-risk drug users in treatment. AIDS Behav. 2017;21:1299\u2013308.","journal-title":"AIDS Behav"},{"key":"4857_CR30","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/ijerph16142620","volume":"16","author":"L Peng","year":"2019","unstructured":"Peng L, Cao W, Gu J, Hao C, Li J, Wei D, et al. Willingness to use and adhere to HIV Pre-Exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China. Int J Environ Res Public Health. 2019;16:2620.","journal-title":"Int J Environ Res Public Health"},{"key":"4857_CR31","doi-asserted-by":"crossref","unstructured":"Shahesmaeili A, Haghdoost AA, Soori H. Developing a brief scale to measure HIV transmission risk among injecting drug users. Int J High Risk Behav Addict. 2015;4(4):e26159.","DOI":"10.5812\/ijhrba.26159"},{"key":"4857_CR32","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10461-011-0003-2","volume":"16","author":"LE Napper","year":"2012","unstructured":"Napper LE, Fisher DG, Reynolds GL. Development of the perceived risk of HIV scale. AIDS Behav. 2012;16:1075\u201383.","journal-title":"AIDS Behav"},{"key":"4857_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","volume":"168","author":"AT McLellan","year":"1980","unstructured":"McLellan AT, Luborsky L, Woody GE, O\u2019BRIEN CP. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J Nerv Ment Dis. 1980;168:26\u201333.","journal-title":"J Nerv Ment Dis"},{"key":"4857_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/QAI.0000000000001213","volume":"74","author":"RA Harris","year":"2017","unstructured":"Harris RA, Xue X, Selwyn PA. Housing stability and medication adherence among HIV-positive individuals in antiretroviral therapy: a meta-analysis of observational studies in the united States. JAIDS J Acquir Immune Defic Syndr. 2017;74:309\u201317.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"4857_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/09540121.2022.2029816","volume":"34","author":"SE Harrison","year":"2022","unstructured":"Harrison SE, Paton,Mariajos\u00e9 M, ,Kathryn E, Vecchio, Alyssa C, Hanson, Lyd A, Hightow-Weidman LB. Do I want PrEP or do I want a roof? Social determinants of health and HIV prevention in the Southern united States. AIDS Care. 2022;34:1435\u201342.","journal-title":"AIDS Care"},{"key":"4857_CR36","doi-asserted-by":"publisher","first-page":"ofy035","DOI":"10.1093\/ofid\/ofy035","volume":"5","author":"A Clemenzi-Allen","year":"2018","unstructured":"Clemenzi-Allen A, Geng E, Christopoulos K, Hammer H, Buchbinder S, Havlir D, et al. Degree of housing instability shows independent Dose-Response with virologic suppression rates among people living with human immunodeficiency virus. Open Forum Infect Dis. 2018;5:ofy035.","journal-title":"Open Forum Infect Dis"},{"key":"4857_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2334-11-86","volume":"11","author":"C Tapp","year":"2011","unstructured":"Tapp C, Milloy M-J, Kerr T, Zhang R, Guillemi S, Hogg RS, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11:86.","journal-title":"BMC Infect Dis"},{"key":"4857_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.socscimed.2007.11.008","volume":"66","author":"K Shannon","year":"2008","unstructured":"Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66:911\u201321.","journal-title":"Soc Sci Med"},{"key":"4857_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11524-010-9534-5","volume":"88","author":"SM Jenness","year":"2011","unstructured":"Jenness SM, Kobrak P, Wendel T, Neaigus A, Murrill CS, Hagan H. Patterns of exchange sex and HIV infection in high-risk heterosexual men and women. J Urban Health. 2011;88:329\u201341.","journal-title":"J Urban Health"},{"key":"4857_CR40","volume-title":"Version 28.0","author":"IBM SPSS Statistics for Windows","year":"2021","unstructured":"IBM SPSS Statistics for Windows. Version 28.0. Armonk, NY: IBM, Corp;; 2021."},{"key":"4857_CR41","unstructured":"Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences. Massachusetts HIV Epidemiologic Profile: Data as of 1\/1\/2023, Population Report: Persons Who Inject Drugs, https:\/\/www.mass.gov\/lists\/hivaids-epidemiologic-profiles. Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences; 2024 Apr."},{"key":"4857_CR42","doi-asserted-by":"crossref","unstructured":"Corcorran MA, Scott JD, Tinsley J, Wald A, Glick SN. Awareness of HIV Pre-Exposure Prophylaxis (PrEP) and Correlates of Interest in PrEP Among HIV-negative People Who Inject Drugs and Access Syringe Services in Seattle, Washington. Substance use & misuse. 2021;57:337.","DOI":"10.1080\/10826084.2021.2012688"},{"key":"4857_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/08897077.2019.1675118","volume":"40","author":"JL Taylor","year":"2019","unstructured":"Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Subst Abus. 2019;40:441\u20133.","journal-title":"Subst Abus"},{"key":"4857_CR44","doi-asserted-by":"publisher","first-page":"S541","DOI":"10.1093\/cid\/ciac716","volume":"75","author":"SE Cooper","year":"2022","unstructured":"Cooper SE, Rosenblatt J, Gulick RM. Barriers to uptake of long-acting antiretroviral products for treatment and prevention of human immunodeficiency virus (HIV) in high-income countries. Clin Infect Dis. 2022;75:S541\u20138.","journal-title":"Clin Infect Dis"},{"key":"4857_CR45","doi-asserted-by":"publisher","first-page":"108058","DOI":"10.1016\/j.jsat.2020.108058","volume":"117","author":"R Shrestha","year":"2020","unstructured":"Shrestha R, DiDomizio EE, Kim RS, Altice FL, Wickersham JA, Copenhaver MM. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. J Subst Abuse Treat. 2020;117:108058.","journal-title":"J Subst Abuse Treat"},{"key":"4857_CR46","unstructured":"Guidelines on Long-Acting Injectable Cabotegravir for HIV Prevention [Internet]. Geneva: World Health Organization. 2022 [cited 2025 Jun 1]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK586584\/"},{"key":"4857_CR47","unstructured":"Centers for Disease Control and Prevention. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 Update: a clinical practice guideline [Internet]. 2021. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/112360"},{"key":"4857_CR48","doi-asserted-by":"publisher","first-page":"e0231424","DOI":"10.1371\/journal.pone.0231424","volume":"15","author":"Y Jo","year":"2020","unstructured":"Jo Y, Bartholomew TS, Doblecki-Lewis S, Rodriguez A, Forrest DW, Tomita-Barber J, et al. Interest in linkage to PrEP among people who inject drugs accessing syringe services; miami, Florida. PLoS ONE. 2020;15:e0231424.","journal-title":"PLoS ONE"},{"key":"4857_CR49","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"L-G Bekker","year":"2024","unstructured":"Bekker L-G, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, et al. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N Engl J Med. 2024;391:1179\u201392.","journal-title":"N Engl J Med"},{"key":"4857_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12889-023-15429-w","volume":"23","author":"AR Bazzi","year":"2023","unstructured":"Bazzi AR, Bordeu M, Baumgartner K, Sproesser DM, Bositis CM, Krakower DS, et al. Study protocol for an efficacy trial of the PrEP for health intervention to increase HIV PrEP use among people who inject drugs. BMC Public Health. 2023;23:513.","journal-title":"BMC Public Health"},{"key":"4857_CR51","doi-asserted-by":"publisher","first-page":"e42585","DOI":"10.2196\/42585","volume":"11","author":"A Khati","year":"2022","unstructured":"Khati A, Altice FL, Vlahov D, Eger WH, Lee J, Bohonnon T, et al. Nurse Practitioner\u2013Led integrated rapid access to HIV prevention for people who inject drugs (iRaPID): protocol for a pilot randomized controlled trial. JMIR Res Protocols. 2022;11:e42585.","journal-title":"JMIR Res Protocols"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04857-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04857-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04857-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:02:39Z","timestamp":1768824159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04857-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4857"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04857-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"31 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing Interests"}}]}}